Patents by Inventor Ghislaine Mayer

Ghislaine Mayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXIDIZED cis-TERPENONE AND ITS USE AS A CHEMOPROTECTIVE AND ANTI-MALARIAL AGENT
    Publication number: 20090149551
    Abstract: 4b,5,6,7,8,8a-cis-hexahydro-2-hydroxy-4b,8,8a-trimethylphenanthren-9,10-dione (OHCT) is a fully oxidized compound based on the 2-hydroxy-cis-terpenone (HCT). Because OHCT is fully oxidized, it is more stable and less likely to damage cells or cell constituents such as DNA. OHCT has antimalarial activity, noncompetitive inhibitory activity against carcinogenic conversion of aflotoxin B1 (AFB1) to exo-AFB1-epoxide thus inihibiting AFB1 induced cellular toxicity, and inhibitory activity against TCDD induced cellular toxicity.
    Type: Application
    Filed: August 22, 2008
    Publication date: June 11, 2009
    Inventors: Qibing Zhou, Ghislaine Mayer, Lin Zhang, Jennifer K. Stewart
  • Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
    Publication number: 20050239730
    Abstract: The invention relates to Plasmodium falciparum Erythrocyte Binding Protein BAEBL for use as a vaccine.
    Type: Application
    Filed: October 2, 2003
    Publication date: October 27, 2005
    Inventors: Ghislaine Mayer, Louis Miller